Hospital-acquired infections are often hard to treat because the corresponding pathogens become increasingly resistant against antibiotics. The bacterium Acinetobacter baumannii is particularly feared ...

Acinetobacter baumannii has emerged as a formidable opportunistic pathogen in hospital settings, notable for its capacity to acquire resistance to nearly all classes of antimicrobial agents. Its role ...

Acinetobacter baumannii is an opportunistic pathogen responsible for high morbidity and mortality in healthcare settings worldwide. Its success stems from a diverse array of virulence determinants and ...

The pathogen Acinetobacter baumannii can survive on hospital surfaces -- without water -- for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now, a team ...

Under a microscope, this drug-resistant superbug looks as benign as a handful of pebbles. Yet carbapenem-resistant Acinetobacter baumannii, or CRAB, is a nightmare for hospitals worldwide, as it kills ...

A research team led by Beate Averhoff and Volker Müller of Goethe University Frankfurt has discovered a fundamental mechanism that helps the dreaded hospital pathogen Acinetobacter baumannii to ...

Researchers have found bacteria often associated with hospital infections in meat samples from markets in Peru. The Barcelona Institute for Global Health (ISGlobal) led the study, published in the ...

Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...

Acinetobacter, like other gram-negative bacteria, has an outer membrane and a cytoplasmic membrane, between which (the periplasmic space) β-lactamases (carbapenemases, AmpC β-lactamases, and ...

Researchers have used machine-learning to identify a potential new antibiotic against a challenging species of disease-causing bacteria, they reported in a paper published in Nature Chemical Biology ...

Acinetobacter baumannii is a bacteria which can become a virulent killer in health-care settings among severely ill patients. The germ has rapidly developed drug resistance to even last-line ...

Credit: Innoviva. Xacduro is available as a kit containing a single dose vial of sulbactam 1g and 2 single-dose vials of durlobactam (0.5g in each vial). Xacduro ® (sulbactam for injection; ...